NanoFUSE Biologics develops the World’s first and only FDA-Approved combination of synthetic bioactive ceramic 45S5 bioglass osteobiologics plus demineralized bone matrix (DBM).
Bioactive glass has been clinically proven for over 30 years. NanoFUSE Biologics LLC was formed in January 2018 to use bioactive glass to create a revolutionary regenerative therapeutic for new bone formation.
NanoFUSE Biologics is a proprietary and patented synthetic bioactive ceramic-based 45S5 bioglass osteobiologic technology. It is the only commercially available synthetic osteobiologic to have two active regenerative bone growth components in a single product: Synthetic ceramic-based bioactive glass + DBM. This unique combination makes NanoFUSE ideal for regenerative bone formation, promoting fusion and bone healing when placed into bony voids or gaps. When NanoFUSE is mixed with an aqueous body fluid, such as blood, there is an immediate release of Calcium, Sodium, Silica and Phosphate ions. This initial reactive causes local pH to increase which is beneficial to increase cell activity and hydroxyapatite production. This creates a 3D ultra porous calcium hydroxyapatite (HA) layer which acts as a scaffold for bone formation in as early as 24 hours.
NanoFUSE Biologics’ regenerative efficacy comes from Osteoinductivity (DBM component), Osteopromotivity and Osteoconductivity (Bioactive glass component).
Advantages
FDA-Approved since Feb 9, 2015
Anti-Microbial
Moldable & Customizable
Flowable Putty
Patented Design & Manufacturing Process
5-Year Sterile Packed Shelf Life
Available in Multiple Forms
Proven Clinical Track Record
